All Stories

  1. Diet, gut microbiome and indoxyl sulphate in chronic kidney disease patients
  2. Association of Anemia and Iron Parameters With Mortality Among Patients Undergoing Prevalent Hemodialysis in Taiwan: The AIM‐HD Study
  3. Hydroxychloroquine Use and Risk of CKD in Patients with Rheumatoid Arthritis
  4. U‐Shaped Association Between Serum Uric Acid Levels With Cardiovascular and All‐Cause Mortality in the Elderly: The Role of Malnourishment
  5. The double-edged sword of endoplasmic reticulum stress in uremic sarcopenia through myogenesis perturbation
  6. Indoxyl Sulfate: A Novel Cardiovascular Risk Factor in Chronic Kidney Disease
  7. Monocyte Chemoattractant Protein-1 Levels and Postangioplasty Restenosis of Arteriovenous Fistulas
  8. Induced Pluripotent Stem Cell-Derived Conditioned Medium Attenuates Acute Kidney Injury by Downregulating the Oxidative Stress-Related Pathway in Ischemia–Reperfusion Rats
  9. Association of estimated glomerular filtration rate with all-cause and cardiovascular mortality: the role of malnutrition-inflammation-cachexia syndrome
  10. Comments on Effects of nitroglycerin ointment on mastectomy flap necrosis in immediate breast reconstruction
  11. Daptomycin antibiotic lock therapy for hemodialysis patients with Gram-positive bloodstream infections following use of tunneled, cuffed hemodialysis catheters: retrospective single center analysis
  12. Evaluation of uraemic pruritus in long-term dialysis patients using a modified Chinese scale
  13. Periodontal Disease and Risks of Kidney Function Decline and Mortality in Older People: A Community-Based Cohort Study
  14. Metformin use and mortality in patients with advanced chronic kidney disease: national, retrospective, observational, cohort study
  15. Thiazolidinediones and Risk of Long-Term Dialysis in Diabetic Patients with Advanced Chronic Kidney Disease: A Nationwide Cohort Study
  16. Interferon gamma-induced protein 10 is associated with insulin resistance and incident diabetes in patients with nonalcoholic fatty liver disease
  17. Association of Hypoglycemia With Incident Chronic Kidney Disease in Patients With Type 2 Diabetes
  18. Association of Fluid Retention With Anemia and Clinical Outcomes Among Patients With Chronic Kidney Disease
  19. Genetic Deletion of Soluble Epoxide Hydrolase Attenuates Inflammation and Fibrosis in Experimental Obstructive Nephropathy
  20. Urinary Calculi and Risk of Cancer
  21. Chronic kidney disease in Taiwan's aging population: Something far more than a distant ship's smoke on the horizon
  22. TREM-1 regulates macrophage polarization in ureteral obstruction
  23. Risk of tuberculosis among healthcare workers in an intermediate-burden country: A nationwide population study
  24. Anaemia management in patients with chronic kidney disease: Taiwan practice guidelines
  25. Association of Postdischarge Rehabilitation with Mortality in Intensive Care Unit Survivors of Sepsis
  26. Associations between the Duration of Dialysis, Endotoxemia, Monocyte Chemoattractant Protein-1, and the Effects of a Short-Dwell Exchange in Patients Requiring Continuous Ambulatory Peritoneal Dialysis
  27. The impact of dialysis therapy on older patients with advanced chronic kidney disease: a nationwide population-based study
  28. Angiotensin-Converting Enzyme Inhibitor or Angiotensin Receptor Blocker Use and Renal Outcomes—Reply
  29. ESA and iron therapy in chronic kidney disease: a balance between patient safety and hemoglobin target
  30. Matrix metalloproteinase-9 deficiency attenuates diabetic nephropathy by modulation of podocyte functions and dedifferentiation
  31. The immediate and one-year outcomes of dialysis patients with refractory angina treated by enhanced external counterpulsation
  32. Estimated Glomerular Filtration Rate Decline Is a Better Risk Factor for Outcomes of Systemic Disease-Related Nephropathy than for Outcomes of Primary Renal Diseases
  33. Volume overload correlates with cardiovascular risk factors in patients with chronic kidney disease
  34. Renoprotective Effect of Renin-Angiotensin-Aldosterone System Blockade in Patients With Predialysis Advanced Chronic Kidney Disease, Hypertension, and Anemia
  35. Benign Pneumatosis Intestinalis
  36. Erythropoiesis-stimulating agents in chronic kidney disease: What have we learned in 25 years?
  37. Interaction Between Geriatric Nutritional Risk Index and Decoy Receptor 3 Predicts Mortality in Chronic Hemodialysis Patients
  38. Immunosuppressant dose reduction and long-term rejection risk in renal transplant recipients with severe bacterial pneumonia
  39. Adipose-Derived Stem Cells Exhibit Antioxidative and Antiapoptotic Properties to Rescue Ischemic Acute Kidney Injury in Rats
  40. Progression of Kidney Disease in Non-Diabetic Patients with Coronary Artery Disease: Predictive Role of Circulating Matrix Metalloproteinase-2, -3, and -9
  41. The benefits of estrogen or selective estrogen receptor modulator on kidney and its related disease—chronic kidney disease—mineral and bone disorder: Osteoporosis
  42. Length Polymorphism in Heme Oxygenase-1 and Cardiovascular Events and Mortality in Hemodialysis Patients
  43. Correction: Intravenous Ferric Chloride Hexahydrate Supplementation Induced Endothelial Dysfunction and Increased Cardiovascular Risk among Hemodialysis Patients
  44. Contrast-induced acute kidney injury in frail older people: What do we learn from the dilemma?
  45. Expression of TNFRSF6B in kidneys is a novel predictor for progression of chronic kidney disease
  46. Aldosterone and Mortality in Hemodialysis Patients: Role of Volume Overload
  47. In-Hospital Mortality Risk Estimation in Patients with Acute Nonvariceal Upper Gastrointestinal Bleeding Undergoing Hemodialysis: A Retrospective Cohort Study
  48. Parathyroidectomy Reduces Intradialytic Hypotension in Hemodialysis Patients with Secondary Hyperparathyroidism
  49. Intravenous Ferric Chloride Hexahydrate Supplementation Induced Endothelial Dysfunction and Increased Cardiovascular Risk among Hemodialysis Patients
  50. High serum DcR3 levels are associated with the occurrence of peritonitis in patients receiving chronic peritoneal dialysis
  51. Induced Pluripotent Stem Cells without c-Myc Attenuate Acute Kidney Injury via Downregulating the Signaling of Oxidative Stress and Inflammation in Ischemia–Reperfusion Rats
  52. Effect of add-on direct renin inhibitor aliskiren in patients with non-diabetes related chronic kidney disease
  53. The non-genomic rapid acidification in peripheral T cells by progesterone depends on intracellular calcium increase and not on Na+/H+-exchange inhibition
  54. Decoy Receptor 3, a Novel Inflammatory Marker, and Mortality in Hemodialysis Patients
  55. Abnormal thyroid function in peritoneal dialysis patients: Lots of smoke but no fire
  56. Progression of Cognitive Dysfunction in Elderly Chronic Kidney Disease Patients in a Veteran's Institution in Central Taiwan: a 3-Year Longitudinal Study
  57. Effects of intravenous iron saccharate on improving severe anemia in rheumatoid arthritis patients
  58. Quiz Page July 2011
  59. Risk factors associated with elevated serum pancreatic amylase levels during hemodialysis
  60. High Risk of Renal Failure in Under-recognized Chronic Kidney Disease: Truth or Myth?
  61. Bone Marrow Iron in CKD: Correlation With Functional Iron Deficiency
  62. Non-genomic rapid inhibition of Na+/H+-exchange 1 and apoptotic immunosuppression in human T cells by glucocorticoids
  63. Oral Bioavailability, Urinary Excretion and Organ Distribution of Melamine in Sprague−Dawley Rats by High-Performance Liquid Chromatography with Tandem Mass Spectrometry
  64. Determination of melamine in rat plasma, liver, kidney, spleen, bladder and brain by liquid chromatography–tandem mass spectrometry
  65. Hemorrhagic Acalculous Cholecystitis: An Unusual Location of Uremic Bleeding
  66. The conundrum of serum ferritin measurement in patients with chronic kidney disease
  67. Cardiorenal Anemia Syndrome in Chronic Kidney Disease
  68. Novel Aspects of Vitamin C in Epoetin Response
  69. Recurrent Hypoglycemia in a Hemodialysis Patient Related to Propoxyphene Treatment
  70. How Can Erythropoietin Requirements be Reduced in Dialysis Patients?
  71. Serum Leptin and Epoetin Sensitivity
  72. High-Calorie Supplementation Increases Serum Leptin Levels and Improves Response to rHuEPO in Long-Term Hemodialysis Patients
  73. Reply from the Author
  74. Protective effect of vitamin C on 8-hydroxy-2′-deoxyguanosine level in peripheral blood lymphocytes of chronic hemodialysis patients
  75. Reply
  76. Hypercalcemia in a renal transplant recipient suffering with Pneumocystis carinii pneumonia
  77. Thiamine deficiency and unexplained encephalopathy in hemodialysis and peritoneal dialysis patients
  78. Peritonitis in CAPD patients--do not always use antibiotics!
  79. Chorea Induced by Thiamine Deficiency in Hemodialysis Patients
  80. An Occult Cause of Arteriovenous Access Failure: Central Vein Stenosis from Permanent Pacemaker Wire
  81. 8-Hydroxy-2′-Deoxyguanosine of leukocyte DNA as a marker of oxidative stress in chronic hemodialysis patients
  82. Effect of vitamin E-bonded membrane on the 8-hydroxy 2′-deoxyguanosine level in leukocyte DNA of hemodialysis patients
  83. Intravenous ascorbic acid as an adjuvant therapy for recombinant erythropoietin in hemodialysis patients with hyperferritinemia
  84. Erythropoietin hyporesponsiveness: From iron deficiency to iron overload
  85. Erythropoietin hyporesponsiveness: From iron deficiency to iron overload
  86. Brachial plexus compression due to subclavian pseudoaneurysm from cannulation of jugular vein hemodialysis catheter
  87. Reply
  88. Improvement of Nutritional Status in Patients Receiving Maintenance Hemodialysis after Correction of Renal Anemia with Recombinant Human Erythropoietin
  89. Internal Jugular Vein Haemodialysis Catheter-induced Right Atrium Endocarditis - Case Report and Review of the Literature
  90. Recombinant Human Erythropoietin Resistance in Iron-Replete Hemodialysis Patients: Role of Aluminum Toxicity
  91. Association of Apolipoprotein E Polymorphism with Lipoprotein Glomerulopathy
  92. Ultrasound-Guided Cannulation of the Internal Jugular Vein for Dialysis Vascular Access in Uremic Patients
  93. Resistance to recombinant erythropoietin in a hemodialysis patient with heterozygous hemoglobinopathy J-Meinung
  94. Uremic pruritus: Roles of parathyroid hormone and substance P
  95. Mathematical Approach for Estimating Iron Needs in Hemodialysis Patients on Erythropoietin Therapy
  96. Hemodialysis-Related Pruritus: A Double-Blind, Placebo-Controlled, Crossover Study of Capsaicin 0.025% Cream
  97. Diabetes Insipidus as an Early Sign of Pineal Tumor
  98. Iron Metabolism Indices for Early Prediction of the Response and Resistance to Erythropoietin Therapy in Maintenance Hemodialysis Patients